Navigation Links
ASH to host agenda-setting scientific meeting on lymphoma biology
Date:8/6/2014

(WASHINGTON, August 6, 2014) The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, will hold its first ASH Meeting on Lymphoma Biology, a meeting focused on furthering the treatment of lymphoma, August 10-13 in Colorado Springs, Colorado. More than 350 lymphoma experts from around the world will attend the meeting to share cutting-edge findings in the field and establish a visionary agenda to accelerate the development of new approaches to understanding and eradicating lymphoma.

Nearly half of all blood cancer cases are lymphomas, or cancers of the lymphatic system. While these diseases are now treatable in many patients and curable in some, the causes of lymphoma are still unknown. The recent U.S. Food and Drug Administration approvals of several targeted drugs to treat non-Hodgkin lymphoma and leukemia, blood cancers which will account for an estimated 123,000i new cancer cases this year in the United States, demonstrate that basic understanding of lymphoma biology can lead to improved therapies for patients.

The goal of the ASH Meeting on Lymphoma Biology is to serve as a forum for scientists to share their knowledge of the biology of this disease and identify the research priorities that they feel will translate to intervention strategies for lymphoma and other cancers affecting the blood.

Data from more than 150 abstracts revealing new insights into lymphoma biology will be presented at the ASH Meeting on Lymphoma Biology, including some that feature updates from presentations from the 2013 ASH Annual Meeting. Examples of the exciting science to be presented include studies exploring a promising therapeutic target for diffuse large B-cell lymphoma, a new oral therapy for non-Hodgkin lymphoma, and resistance to ibrutinib.

In addition to abstract presentations, the ASH Meeting on Lymphoma Biology will feature interactive sessions led by more than 30 renowned speakers. Klaus Rajewsky, MD, of the Max Delbruck Center for Molecular Medicine in Berlin will deliver the meeting's keynote address on immune regulation and cancer.

Following the meeting ASH will release a white paper summarizing past and present lymphoma research breakthroughs and establishing a collaborative roadmap of key lymphoma research priorities to be shared with investigators and funding agencies.

"The ASH Meeting on Lymphoma Biology, an ASH scientific meeting focused exclusively on basic and translational lymphoma research advances, underscores the Society's commitment to fostering critical collaboration among lymphoma experts that will help conquer this disease," said ASH President Linda J. Burns, MD, of the University of Minnesota. "Attendees will have a unique opportunity to help chart the course of future lymphoma research and will come away with a better understanding of the disease."


'/>"/>

Contact: Amanda Szabo
aszabo@hematology.org
202-552-4914
American Society of Hematology
Source:Eurekalert

Related medicine news :

1. MonaVie Adds Cosmetics Industry Veteran Diane Miles to Its Scientific Advisory Board
2. In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com
3. MonaVie Adds Nutritionist Mark Macdonald to Its Scientific Advisory Board
4. Cocaine, cash and chemistry: 4 scientifically rich facts about money (video)
5. Einstein & Montefiore present research at American Diabetes Association Scientific Sessions
6. Cell biologists top scientific honor goes to pioneers of the cytoskeleton
7. The latest in scientific research in childrens health to be presented in Vancouver
8. Real-world heart procedure results consistent with scientific research
9. A scientific first: Physicists, physicians, engineers photograph radiation beams in the human body through the Cherenkov effect
10. Getting a cancer drug to patients takes both scientific and business smarts
11. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order Pertaining to Discovery in Federal Boston Scientific Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by ... require dental technicians to be certified or obtain continuing education. To increase patient ... “What’s In Your Mouth?” campaign to inform dentists and patients about the possible ...
(Date:2/7/2016)... Clarkston, Metamora, Michigan (PRWEB) , ... February 07, 2016 , ... ... in recognition of National Wear Red Day. National Wear Red Day is the ... stroke in women. Heart disease and stroke cause 1 in 3 deaths among women ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... ... February 06, 2016 , ... US Sports Camps is proud to ... This event brings together top non-profit leaders, ultimate organizations, and coaches from around the ... Iani, Bay Area Disc Program Director of Youth and Education, describes this year YUCC ...
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds and Kevin ... of a new DRTV campaign with Belly Bands. , Having a dog is great—except ... to puppy pads and find nothing works, get Belly Bands, the easiest way ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... part of a major growth and expansion initiative, Dune Medical ... Chmura as President of Dune Inc., its U.S. division. ... experience in the medical device space will play a large ... --> --> In her new ... and operational functions in the U.S. She is tasked with ...
(Date:2/8/2016)... Mich. , Feb. 8, 2016  The University ... announced today that, as part of the ... one of the first hospitals in the U.S. to ... Karin Muraszko , M.D., U-M,s chair of neurosurgery. ... of neurosurgery. --> The BrightMatter technology ...
(Date:2/8/2016)...  Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced ... December 31, 2015, the Company achieved revenue of $8,195,839, a ... quarter in fiscal 2015. --> ... year 2016 was $2,068,635, or $.03 per share, up 265% ... in the Q2 of fiscal year 2015. Gross margin for ...
Breaking Medicine Technology: